Variant report
Variant | nsv599618 |
---|---|
Chromosome Location | chr5:120853669-120911071 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:120873429..120875886-chr5:120876778..120878450,2 | K562 | blood: | |
2 | chr5:120873429..120875886-chr5:120876778..120878450,2 | K562 | blood: | |
3 | chr5:120597959..120600237-chr5:120894989..120897698,2 | K562 | blood: | |
4 | chr5:120906813..120909196-chr5:120909743..120912728,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000244088 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17147959 | chr5:120853669-120853670 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs182453919 | chr5:120853715-120853716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs528763242 | chr5:120853764-120853765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs150745603 | chr5:120853779-120853780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs540951271 | chr5:120853783-120853784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs565607788 | chr5:120853794-120853795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs62379188 | chr5:120853828-120853829 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs551196781 | chr5:120853832-120853833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567172918 | chr5:120853865-120853866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs17147961 | chr5:120853882-120853883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7722012 | chr5:120853928-120853929 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs186770988 | chr5:120853933-120853934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11750922 | chr5:120853959-120853960 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs139170284 | chr5:120853983-120853984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563446554 | chr5:120860837-120860838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs527520338 | chr5:120860876-120860877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs528078187 | chr5:120860902-120860903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539893069 | chr5:120860925-120860926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565142151 | chr5:120860979-120860980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs117701746 | chr5:120860987-120860988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34924396 | chr5:120861026-120861027 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs529943855 | chr5:120861042-120861043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548687053 | chr5:120861069-120861070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145493450 | chr5:120861121-120861122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534196275 | chr5:120861161-120861162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs561842945 | chr5:120861162-120861163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs116242320 | chr5:120861167-120861168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs551662013 | chr5:120864204-120864205 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
29 | rs148765338 | chr5:120864221-120864222 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
30 | rs75204288 | chr5:120864227-120864228 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144972629 | chr5:120864231-120864232 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
32 | rs559714541 | chr5:120864254-120864255 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
33 | rs79098829 | chr5:120864269-120864270 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147534177 | chr5:120864308-120864309 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
35 | rs545667225 | chr5:120864312-120864313 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
36 | rs9885396 | chr5:120864326-120864327 | ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs531124957 | chr5:120864359-120864360 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
38 | rs549598936 | chr5:120864381-120864382 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
39 | rs545681845 | chr5:120864492-120864493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs192354190 | chr5:120864507-120864508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs184404376 | chr5:120864517-120864518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564277325 | chr5:120864523-120864524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561723366 | chr5:120864559-120864560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs188862975 | chr5:120864591-120864592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs547049229 | chr5:120864592-120864593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs70985286 | chr5:120864600-120864601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs111885663 | chr5:120869468-120869469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs533081620 | chr5:120869506-120869507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537644105 | chr5:120869523-120869524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549672053 | chr5:120869530-120869531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:120853200-120854000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr5:120860800-120861200 | Enhancers | Hela-S3 | cervix |
3 | chr5:120864200-120864400 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr5:120864400-120864600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr5:120869400-120871000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr5:120869400-120871400 | Enhancers | Fetal Heart | heart |
7 | chr5:120870000-120871200 | Enhancers | Right Atrium | heart |
8 | chr5:120870200-120870800 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
9 | chr5:120870200-120871200 | Enhancers | Left Ventricle | heart |
10 | chr5:120870400-120870800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr5:120870400-120871000 | Enhancers | Right Ventricle | heart |
12 | chr5:120871000-120871200 | Flanking Active TSS | Gastric | stomach |
13 | chr5:120880800-120881400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr5:120897200-120898000 | ZNF genes & repeats | Dnd41 | blood |
15 | chr5:120907400-120911000 | Enhancers | Dnd41 | blood |
16 | chr5:120908000-120908200 | Enhancers | NH-A | brain |
17 | chr5:120909400-120910000 | Enhancers | Fetal Lung | lung |
18 | chr5:120909600-120910000 | Enhancers | Fetal Heart | heart |
19 | chr5:120909800-120910200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |